Anpac Bio (@AnpacBio) header
Anpac Bio (@AnpacBio) profile picture

Anpac's proprietary Cancer Differentiation Analysis devices/technology measures simple “Blood Biopsies” identifying 26 early-stage cancers with 75-90% accuracy.

California, USA
Joined January 2016
Industry News:   Simple Blood Test Could Help Doctors Decide Cancer Treatment  ibn.fm/5NIY1    #cancer
1
Industry News:   Simple Blood Test Could Help Doctors Decide Cancer Treatment  ibn.fm/Ehg1v    #cancer
Industry News:    Potential Treatment Identified For Bladder Cancers That Are ARID1A-Deficient  ibn.fm/tvoL1   #cancer
1
Industry News:  Indian Cancer Doctors Talk About The Miracle Drug ‘Dostarlimab’ Trial That Completely Removed Cancer ibn.fm/gMAGv      #cancer
1
Industry News:  Revolutionary New Cancer Therapy Offers A More Targeted Approach Against Non-Hodgkin’s Lymphoma ibn.fm/b1LSs     #cancer
Industry News:  Report Available: Global Genomic Cancer Panel and Profiling Markets, Q3 2022-2026  ibn.fm/2ot9k     #cancer
1
Industry News:   Next Generation Sequencing Market to Reach $33.73 billion By 2028 Thanks to Increased Attention Early Disease Diagnosis and High Prevalence of Cancer   ibn.fm/QBR9N   #cancer
1
Industry News:  Motherhood Doesn't Lower Survival for Women Who've Had Breast Cancer ibn.fm/CoFrm     #cancer
Industry News:   Report Available - Cervical Cancer Diagnostics Market Technology Type Analysis, Size, Share, Growth, Price Trends, and Forecast To 2030 ibn.fm/dunos     #cancer
1
Industry News:   $200+ Billion Cancer Diagnostics Markets – Report  ibn.fm/lIEwE    #cancer